Table 2.
The concentration of sTNF-RI and TNF-α in COVID-19 patients and healthy subjects according to ICU status.
| ICU-patients n=17 | Healthy n=15 | P value | Non-ICU patients n=29 | Healthy n=15 | P value | ICU-patients n=17 | Non-ICU patients n=29 | P value | |
|---|---|---|---|---|---|---|---|---|---|
| sTNF-RI (pg/ml) | 2842(1197-3789)* | 917.3 (260-1479)* | <0.0001 | 1061 (633.4-1991)* | 917.3 (260-1479)* | 0.0342 | 2654 ± 187† | 1144 ± 66.58† | <0.0001 |
| TNF-α (pg/ml)† | 7.18 ± 0.94 | 0.200 ± 0.038 n=8 |
<0.0001 | 5.73 ± 0.26 | 0.200 ± 0.0380 n=8 |
<0.0001 | 7.18 ± 0.94 | 5.73 ± 0.26 | 0.0725 |
| ICU-patients n=12 |
Healthy n=8 |
P value | Non-ICU patients n=8 |
Healthy n=8 |
P value | ICU-patients n=12 |
Non-ICU patients n=8 |
P value | |
| IL-6 (pg/ml)* | 21.3 (1.94-3612) | 0.1 (0.1-12.8) | 0.0014 | 9.25 (1.94-58.9) | 0.1 (0.1-12.8) | 0.0135 | 21.3 (1.94-3612) | 9.25 (1.94-58.9) | 0.2454 |
†Values are presented as mean ± sem.
* Values are presented as median (5-95% percentile).